Clinical Trial Update: Mycophenolate Mofetil in Systemic Lupus Erythematosus (MISSILE) [Phase 4]

View source ↗

Summary

The MISSILE Phase 4 trial of mycophenolate mofetil for systemic lupus erythematosus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Systemic Lupus Erythematosus

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)

Snippet

Sponsor: Guy's and St Thomas' NHS Foundation Trust | Conditions: Systemic Lupus Erythematosus, Atherosclerosis | Phase 4 | Status: COMPLETED